Contact person
Mark Hawthorne - VP Business Development
- Title: VP Business Development
- E-mail:
- Phone: +44 7748 988705
- Alt phone: +001 781 697 9583
Oct 13, 2011 15:23 CEST The unique features of TIGR® Matrix Surgical Mesh have been recognized with the first U.S. patent now granted.
Aug 16, 2011 13:52 CEST Singapore /PRNewswire/ — Novus Scientific Pte. Ltd announced today that it has received CE Mark approval for TIGR® Matrix Surgical Mesh, the world’s first long-term resorbable synthetic mesh. TIGR® Matrix is indicated for reinforcement of soft tissue where weakness exists.
Jun 15, 2011 14:31 CEST Novus Scientific today announced that Tulane University School of Medicine and Department of Veterans Affairs have granted IRB approval to a new trial: A Study Evaluating Efficacy of TIGR® Matrix Surgical Mesh used in Elective Open Inguinal Hernia Repair.
Jun 01, 2011 14:29 CEST Novus Scientific today announced the joint sponsorship with Florida Hospital of; ‘ADVANCES in ABDOMINAL SURGERY: a symposium for General Surgeons & Plastic Surgeons in Florida’ to be held June 2nd, 2011. This is the first “SOFTissue – The Issue of Soft Tissue” educational series to be conducted in the U.S. and will be held at the Creation Conference Center at Florida Hospital, Orlando, FL..
May 23, 2011 14:27 CEST Singapore, /PRNewswire/ — Singapore company Novus Scientific Pte. Ltd announced that the TRAM Flap study (Abdominal Wall Closure After Lipectomy, TRAM/DIEP Flap – Comparison of TIGR® (100% Resorbable) vs Polypropylene (Permanent) Mesh) has passed the 20 patient mark, representing approximately one quarter of the 86 patient study compliment.
May 10, 2011 14:25 CEST Singapore /PRNewswire/ — Novus Scientific Pte. Ltd today announced that it will be exhibiting at EHS 2011 in Ghent, Belgium ahead of receiving its anticipated CE Mark approval this year for TIGR® Matrix Surgical Mesh, the World’s 1st Long-Term Resorbable Synthetic Mesh.
Jan 25, 2011 14:23 CET Novus Scientific Pte. Ltd, a Singapore company, announced today that Dr. James Chao of the University of California San Diego (UCSD) has operated on his first TRAM Flap patient using TIGR® Matrix Surgical Mesh.
Nov 03, 2010 14:11 CET Featuring James J Chao, M.D., FACS, Professor of Plastic Surgery and Orthopedic Surgery, University of California, San Diego Singapore company Novus Scientific Pte. Ltd today announced the successful hosting of Asia’s 1st “SOFTISSUE – The Issue of Soft Tissue” educational series, together with the Singapore Association of Plastic Surgeons (SAPS) on 1st November 2010.
Oct 25, 2010 14:06 CEST Singapore company Novus Scientific Pte. Ltd today announced that the National University Hospital (NUH), Singapore has operated on the first patient in it’s groundbreaking study: Abdominal Wall Closure After Lipectomy, TRAM/DIEP Flap – Comparison of TIGR® Matrix (100% Resorbable) vs Polypropylene (Permanent) Mesh
Sep 13, 2010 13:29 CEST Novus Scientific Pte. Ltd today announced that the National University Hospital (NUH), Singapore has received Domain Specific Review Board (DSRB i.e. IRB equivalent) provisional approval for a new study: Abdominal Wall Closure After Lipectomy, TRAM/DIEP Flap – Comparison of TIGR® (100% Resorbable) vs Polypropylene (Permanent) Mesh
Jun 17, 2010 13:26 CEST CANTON, Mass., June 17 /PRNewswire/ — Novus Scientific, Inc. today announced the US sales launch of TIGR® Matrix Surgical Mesh at the Abdominal Wall Reconstruction meeting, Washington DC. In February 2010, the US Food and Drug Administration (FDA) cleared, TIGR® Matrix Surgical Mesh for use in reinforcement of soft tissues where weakness exists.
Aug 15, 2011 15:21 CEST the World’s First Long-Term Resorbable Synthetic Mesh
You haven't entered a correct link to your helper.html file for your Hosted Newsroom. Go to Publish and complete the steps.
Add commentThe comment was saved
Prior to publication, it must be approved by Novus Scientific.